| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |